+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration



Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration



Journal of Pharmaceutical Sciences 74(9): 915-921



Liposomal encapsulation can limit passage of a drug from a peritoneal administration site to blood, while enhancing lymphatic transport. We evaluated the effects of liposome size on lymphatic transport after intraperitoneal administration. Liposomes tested had mean diameters of either 0.72, 0.46, 0.17, or 0.048 micron and identical compositions. [14C]Sucrose was the aqueous space marker (model drug). Doses were given to thoracic-duct-cannulated rats. The subsequent 0-5 h time-course of carbon-14 was quantified in thoracic lymph, several lymph nodes, blood, and urine. Calibration studies indicated a maximum of approximately 30% of the absorbed dose could be collected in thoracic lymph. Carbon-14 levels in the various nodes covered a 1000-fold range, and relatively high levels were observed in the left mediastinal, parathymic, cisternal, and renal lymph nodes. Liposome stability in vivo and in vitro increased with decreasing size. Absorption from the peritoneal cavity was independent of size. The smallest liposomes were collected in lymph with little lymph node retention. The largest liposomes were retained most by lymph nodes, and would be the best prototypical carrier of the group if increased therapeutic availability within both lymph and lymph nodes is desired. The results implicate other, unexplored physical and physiological variables as potentially of equal importance.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 040612781

Download citation: RISBibTeXText

PMID: 4067845

DOI: 10.1002/jps.2600740902


Related references

Lymphatic transport of liposome-encapsulated drugs following intraperitoneal administration - effect of lipid composition. Pharmaceutical Research 2(6): 271-278, 1985

Lymphatic absorption and tissue disposition of liposome-entrapped [14C]adriamycin following intraperitoneal administration to rats. Cancer Research 41(4): 1311-1317, 1981

Biocompatibility of HbV: Liposome-Encapsulated Hemoglobin Molecules-Liposome Effects on Immune Function. Journal of Functional Biomaterials 8(3), 2017

The effect of surface charge on the disposition of liposome-encapsulated gentamicin to the rat liver, brain, lungs and kidneys after intraperitoneal administration. International Journal of Antimicrobial Agents 25(5): 392-397, 2005

Macrophage depletion in the rat after intraperitoneal administration of liposome-encapsulated clodronate: Depletion kinetics and accelerated repopulation of peritoneal and omental macrophages by administration of Freund's adjuvant. Cell and Tissue Research 280(1): 189-196, 1995

Intraperitoneal administration of liposome encapsulated muramyl tripeptide phosphoethanolamine mtp pe with or without recombinant murine gm csf to athymic mice bearing human ovarian cancer xenografts. Proceedings of the American Association for Cancer Research Annual Meeting 30: 411, 1989

Comparison of lymphatic uptake, metabolism, excretion, and biodistribution of free and liposome-entrapped [14C]cytosine beta-D-arabinofuranoside following intraperitoneal administration to rats. Drug Metabolism and Disposition: the Biological Fate of Chemicals 10(1): 40-46, 1982

Studies on liposome encapsulated carboquone 3. enhancement of lymphatic transport of carboquone by encapsulation. Journal of Pharmacobio Dynamics 5(1): 27-33, 1982

Studies on liposome-encapsulated carboquone. III. Enhancement of lymphatic transport of carboquone by encapsulation. Journal of Pharmacobio-Dynamics 5(1): 27-33, 1982

Time-resolved infrared ATR measurements of liposome transport kinetics in human keratinocyte cultures and skin reveals a dependence on liposome size and phase state. Journal of Investigative Dermatology 105(2): 291-295, 1995

The effects of liposome size and surface charge on liposome-mediated delivery of methotrexate-gamma-aspartate to cells in vitro. Biochimica et Biophysica Acta 820(1): 74-84, 1985

Imaging-based analysis of liposome internalization to macrophage cells: Effects of liposome size and surface modification with PEG moiety. Colloids and Surfaces. B, Biointerfaces 136: 786-790, 2016

In vitro cytotoxicity of liposome-encapsulated doxorubicin: Dependence on liposome composition and drug release. Biochimica et Biophysica Acta 1109(2): 203-209, 1992

Competitive Trapping of Nitric Oxide (NO) Between Fe(III)-dithiocarbamate Complex and Liposome-encapsulated Trimethylammonio-PTIO: Effects of Ligand Structure, Charge on Liposome Surface, and External Pressure on NO-trapping Rates. Applied Magnetic Resonance 39(3): 261-272, 2010

Decreased toxicity in-vitro of liposome encapsulated mitoxantrone and macrophage phagocytosed liposome-encapsulated mitoxantrone. Journal of Pharmacy & Pharmacology 45(SUPPL 2): 1120, 1993